Now Playing
Opinion|Videos|March 28, 2025
Real-World Insights on Tildrakizumab
Author(s)Aaron Farberg, MD
An expert discusses how the study assessed real-world effectiveness of tildrakizumab for moderate to severe plaque psoriasis, crucial for validating clinical trial results. Multisite data enhanced reliability, while a systematic review and meta-analysis confirmed efficacy, safety, and quality of life benefits, aligning with trial findings.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- What was the key background information for this abstract on real-world effectiveness of tildrakizumab, and why was it so important to examine this therapy in a real-world setting?
- Describe the value of having many clinical sites included in this study.
- What was the study design for this study examining real-world effectiveness of tildrakizumab?
- Do these results match up with what was seen in the clinical trials for tildrakizumab?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Advertisement
Advertisement
